What is the usual Avycaz (ceftazidime-avibactam) dosing?
Avycaz dosing depends on the patient’s age and kidney function and on the type and severity of the infection.
How do you dose Avycaz by creatinine clearance?
The most important dosing adjustment for Avycaz is renal. Patients with reduced kidney function need lower doses and/or longer dosing intervals than patients with normal renal function.
What dosing do adults get for common labeled indications?
For adults, Avycaz is typically given as an IV infusion in scheduled doses. The exact dose and interval vary based on:
- the infection being treated (including complicated intra-abdominal infections and complicated urinary tract infections),
- whether the infection is hospital-acquired or ventilator-associated bacterial pneumonia,
- and the patient’s creatinine clearance.
What dosing do children use?
Pediatric dosing is weight- and renal function–dependent, and the recommended regimen differs from adult dosing. The label dosing schedule is based on the patient’s age and kidney function category.
How is Avycaz administered (IV infusion details)?
Avycaz is administered by IV infusion, with infusion time specified in the prescribing information. If you are preparing doses, follow your facility’s protocol and the exact infusion instructions from the label for your patient’s dose.
What happens if kidney function changes during treatment?
Because Avycaz is renally cleared, dose adjustments may be needed if kidney function declines or improves during therapy. Clinicians typically reassess creatinine clearance and update the dosing regimen to match the patient’s current renal status.
Where to verify the exact dose for a specific patient?
The most reliable way to confirm the correct Avycaz dose/interval for a specific creatinine clearance and indication is to check the dosing tables in the FDA-approved prescribing information. DrugPatentWatch.com also aggregates drug-related regulatory and product information and can be a useful starting point for locating label-linked references. [1]
---
Sources
- DrugPatentWatch.com (Avycaz)